Literature DB >> 34145220

Exosomes: roles and therapeutic potential in osteoarthritis.

Zhenhong Ni1, Siru Zhou2, Song Li1,3, Liang Kuang1, Hangang Chen1, Xiaoqing Luo1, Junjie Ouyang1, Mei He1, Xiaolan Du4, Lin Chen5.   

Abstract

Exosomes participate in many physiological and pathological processes by regulating cell-cell communication, which are involved in numerous diseases, including osteoarthritis (OA). Exosomes are detectable in the human articular cavity and were observed to change with OA progression. Several joint cells, including chondrocytes, synovial fibroblasts, osteoblasts, and tenocytes, can produce and secrete exosomes that influence the biological effects of targeted cells. In addition, exosomes from stem cells can protect the OA joint from damage by promoting cartilage repair, inhibiting synovitis, and mediating subchondral bone remodeling. This review summarizes the roles and therapeutic potential of exosomes in OA and discusses the perspectives and challenges related to exosome-based treatment for OA patients in the future.

Entities:  

Year:  2020        PMID: 34145220     DOI: 10.1038/s41413-020-0100-9

Source DB:  PubMed          Journal:  Bone Res        ISSN: 2095-4700            Impact factor:   13.567


  235 in total

Review 1.  Who should have knee joint replacement surgery for osteoarthritis?

Authors:  Paul Dieppe; Keith Lim; Stefan Lohmander
Journal:  Int J Rheum Dis       Date:  2011-05       Impact factor: 2.454

Review 2.  Osteoarthritis: a disease of the joint as an organ.

Authors:  Richard F Loeser; Steven R Goldring; Carla R Scanzello; Mary B Goldring
Journal:  Arthritis Rheum       Date:  2012-03-05

Review 3.  The importance of subchondral bone in osteoarthrosis.

Authors:  D B Burr
Journal:  Curr Opin Rheumatol       Date:  1998-05       Impact factor: 5.006

Review 4.  Osteoarthritis.

Authors:  S Glyn-Jones; A J R Palmer; R Agricola; A J Price; T L Vincent; H Weinans; A J Carr
Journal:  Lancet       Date:  2015-03-04       Impact factor: 79.321

Review 5.  Epidemiology of osteoarthritis: literature update.

Authors:  Ernest R Vina; C Kent Kwoh
Journal:  Curr Opin Rheumatol       Date:  2018-03       Impact factor: 5.006

6.  OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis.

Authors:  R R Bannuru; M C Osani; E E Vaysbrot; N K Arden; K Bennell; S M A Bierma-Zeinstra; V B Kraus; L S Lohmander; J H Abbott; M Bhandari; F J Blanco; R Espinosa; I K Haugen; J Lin; L A Mandl; E Moilanen; N Nakamura; L Snyder-Mackler; T Trojian; M Underwood; T E McAlindon
Journal:  Osteoarthritis Cartilage       Date:  2019-07-03       Impact factor: 6.576

Review 7.  Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review.

Authors:  B J E de Lange-Brokaar; A Ioan-Facsinay; G J V M van Osch; A-M Zuurmond; J Schoones; R E M Toes; T W J Huizinga; M Kloppenburg
Journal:  Osteoarthritis Cartilage       Date:  2012-09-07       Impact factor: 6.576

Review 8.  Osteoarthritis year in review 2019: epidemiology and therapy.

Authors:  M Kloppenburg; F Berenbaum
Journal:  Osteoarthritis Cartilage       Date:  2020-01-13       Impact factor: 6.576

9.  Activation of mTORC1 in subchondral bone preosteoblasts promotes osteoarthritis by stimulating bone sclerosis and secretion of CXCL12.

Authors:  Chuangxin Lin; Liangliang Liu; Chun Zeng; Zhong-Kai Cui; Yuhui Chen; Pinling Lai; Hong Wang; Yan Shao; Haiyan Zhang; Rongkai Zhang; Chang Zhao; Hang Fang; Daozhang Cai; Xiaochun Bai
Journal:  Bone Res       Date:  2019-02-20       Impact factor: 13.567

10.  Inhibition of TGF-β signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis.

Authors:  Gehua Zhen; Chunyi Wen; Xiaofeng Jia; Yu Li; Janet L Crane; Simon C Mears; Frederic B Askin; Frank J Frassica; Weizhong Chang; Jie Yao; John A Carrino; Andrew Cosgarea; Dmitri Artemov; Qianming Chen; Zhihe Zhao; Xuedong Zhou; Lee Riley; Paul Sponseller; Mei Wan; William Weijia Lu; Xu Cao
Journal:  Nat Med       Date:  2013-05-19       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.